IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q3 2021 Holdings

Filed 2021-11-15 | 38 holdings | $9.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Moderna Inc(MRNA)COM60770K107$6.8M17,581,01670.9%
Sana Biotechnology Inc(SANA)COM799566104$771.1K34,239,0188.1%
Rubius Therapeutics IncCOM78116T103$688.5K38,506,5267.2%
Omega Therapeutics IncCOM68217N105$488.3K25,902,2695.1%
Foghorn Therapeutics Inc(FHTX)COM344174107$176.6K12,674,1201.8%
Evelo Biosciences IncCOM299734103$162.1K23,030,0691.7%
Denali Therapeutics Inc(DNLI)COM24823R105$137.7K2,730,2631.4%
Kaleido Biosciences Inc(KLDO)COM483347100$106.9K19,575,7101.1%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$100.1K14,378,8021.0%
Sigilon Therapeutics IncCOM82657L107$58.6K10,370,3690.6%
Codiak Biosciences Inc(32W)COM192010106$42.6K2,607,3030.4%
Axcella Health IncCOM05454B105$37.4K12,548,4140.4%
Syros Pharmaceuticals IncCOM87184Q107$13.1K2,938,4940.1%